Highlights the rare presentation of thyrotoxic periodic paralysis and its rapid resolution with potassium, antithyroid drugs, and beta-blockers.
Supports empiric potassium and antithyroid therapy in suspected thyrotoxic periodic paralysis; hypothesis-generating from single case report.
Thyrotoxic periodic paralysis is a rare condition with only sporadic cases described in the medical literature. It occurs as a neuromuscular disorder characterized by recurrent attacks of severe muscle weakness associated with low serum potassium and thyrotoxicosis. We report the unusual case of a 21-year-old man who complained of lack of strength in his legs and generalized weakness in his upper and lower limbs, severe hypokalemia was detected during routine laboratory examinations. Thyrotoxic periodic paralysis as the underlying cause was suggested by suppressed thyroid stimulating hormone, elevated free T3 and free T4, and the presence of thyroid stimulating hormone-receptor antibodies. Treatment with intravenous potassium, an antithyroid drug, nonspecific beta-blocker, and anxiolytic agents resulted in a rapid resolution of symptoms. We also discuss the pathogenesis and characteristics of this rare disorder by reviewing the current medical literature.
No takes yet. Share an insight, caveat, or question.
Rădulescu et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: